You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 31 Next »

This example dataset shows the findings associated with a Cardiac Magnetic Resonance Imaging procedure related to late gadolinium enhancement.

The Procedures (PR) dataset is an interventions domain that represents diagnostic, preventive, and therapeutic activity. The PR dataset shows the cardiac magnetic resonance imaging with two different MR machines.


TO DO- Describe the analysis method for LGE - three different methods:

  • Full-width half maximum
  • 5 standard deviations
  • 6 standard deviations

These are represented in the ANMETH variable describes the analysis method applied to obtain a summarized result. Analysis method describes the method of secondary processing applied to a complex observation result (e.g., an image, a genetic sequence) which in this case applies to the CMR imaging.

Row 1:Shows a cardiac MRI for participant 201.
Row 2:Shows a cardiac MRI for participant 202 with a different MRI machine. The time of the procedure was not available so only the date is shown in the PRSTDTC variable.

pr.xpt

pr.xpt

Row

STUDYID

DOMAIN

USUBJID

SPDEVID

PRSEQ

PRREFID

PRLNKID

PRTRT

PRFAST

PRSTDTC

1

DMD-LGE

PR

201

ABC001

1

12345678

04

CARDIAC MAGNETIC RESONANCE IMAGING

Y

2023-07-01T09:15:00

2

DMD-LGE

PR

202

ABC002

1

98765432

05

CARDIAC MAGNETIC RESONANCE IMAGING

N

2020-07-05

$warningHtml

Dataset Wrapper Debug Message

Please add a row column to your dataset.

The Cardiovascular System Findings (CV) dataset contains physiological and morphological findings related to the cardiovascular system, including the heart, blood vessels and lymphatic vessels. The findings from the CMR procedure for LGE are noted in this example. If LGE was not performed, it would not appear in the dataset.
Row 1:Shows the late gadolinium enhancement (LGE) is positive for the overall Left Ventricle for participant 201.
Row 2:Shows the late gadolinium enhancement (LGE) overall Left Ventricle percentage is 40% for participant 201.
Rows 3-18:Show the segmental late gadolinium enhancement (LGE) values for each of the left ventricle segments for participant 201.
Row 19:Shows the total late gadolinium enhancement (LGE) positive segments for participant 201.
Rows 20-23:Show the segmental late gadolinium enhancement (LGE) percentage for each of the positive LGE segments for participant 201.
Row 24:Shows the late gadolinium enhancement (LGE) is negative for participant 202.

cv.xpt

cv.xpt

Row

STUDYID

DOMAIN

USUBJID

CVSEQ

CVLNKID

CVTESTCD

CVTEST

CVORRES

CVORRESU

CVSTRESC

CVSTRESN

CVSTRESU

CVLOC

CVMETHOD

CVANMETH

VISITNUM

VISIT

CVDTC

1DMD-LGECV201104LGELATE GADOLINIUM ENHANCEMENT

POSITIVE


POSITIVE



LEFT VENTRICLECARDIAC MAGNETIC RESONANCE IMAGINGVISUAL1SCREENING2023-07-01
2DMD-LGECV201204TLGEPRTOTAL LATE GADOLINIUM ENHANCEMENT PERCENTAGE

40

%

40

40%LEFT VENTRICLECARDIAC MAGNETIC RESONANCE IMAGINGQUANTITATIVE1SCREENING2023-07-01
3DMD-LGECV201304SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENTNEGATIVE

NEGATIVE



LEFT VENTRICULAR BASAL ANTERIOR SEGMENTCARDIAC MAGNETIC RESONANCE IMAGINGVISUAL


4DMD-LGECV201404SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

POSITIVE


POSITIVE



LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGINGVISUAL


5DMD-LGECV201504SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

POSITIVE


POSITIVE



LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGINGVISUAL


6DMD-LGECV201604SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR BASAL INFERIOR SEGMENTCARDIAC MAGNETIC RESONANCE IMAGINGVISUAL


7DMD-LGECV201704SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR BASAL INFEROLATERAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGINGVISUAL


8DMD-LGECV201804SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR ANTEROLATERAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGINGVISUAL


9DMD-LGECV201904SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR MID ANTERIOR SEGMENTCARDIAC MAGNETIC RESONANCE IMAGINGVISUAL


10DMD-LGECV2011004SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

POSITIVE


POSITIVE



LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGINGVISUAL


11DMD-LGECV2011104SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

POSITIVE


POSITIVE



LEFT VENTRICULAR INFEROSEPTAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGINGVISUAL


12DMD-LGECV2011204SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR MID INFERIOR SEGMENTCARDIAC MAGNETIC RESONANCE IMAGINGVISUAL


13DMD-LGECV2011304SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR MID INFEROLATERAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGINGVISUAL


14DMD-LGECV2011404SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR ANTEROLATERAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGINGVISUAL


15DMD-LGECV2011504SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR APICAL ANTERIOR SEGMENTCARDIAC MAGNETIC RESONANCE IMAGINGVISUAL


16DMD-LGECV2011604SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR APICAL SEPTAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGINGVISUAL


17DMD-LGECV2011704SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR APICAL INFERIOR SEGMENTCARDIAC MAGNETIC RESONANCE IMAGINGVISUAL


18DMD-LGECV2011804SGTLGESEGMENTAL LATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICULAR APICAL LATERAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGINGVISUAL


19DMD-LGECV2011904TLGETOTAL LGE SEGMENTS

4


4

4
LEFT VENTRICLECARDIAC MAGNETIC RESONANCE IMAGINGVISUAL1SCREENING2023-07-01
20DMD-LGECV2012004LGEPERLATE GADOLINIUM ENHANCEMENT PERCENTAGE

40

%

40

40%LEFT VENTRICULAR BASAL ANTEROSEPTAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGINGFULL-WIDTH HALF MAXIMUM1SCREENING2023-07-01
21DMD-LGECV2012104LGEPERLATE GADOLINIUM ENHANCEMENT PERCENTAGE

20

%

20

20%LEFT VENTRICULAR BASAL INFEROSEPTAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGINGFULL-WIDTH HALF MAXIMUM1SCREENING2023-07-01
22DMD-LGECV2012204LGEPERLATE GADOLINIUM ENHANCEMENT PERCENTAGE

45

%

45

45%LEFT VENTRICULAR MID ANTEROSEPTAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGINGFULL-WIDTH HALF MAXIMUM1SCREENING2023-07-01
23DMD-LGECV2012304LGEPERLATE GADOLINIUM ENHANCEMENT PERCENTAGE

20

%

20

20%LEFT VENTRICULAR INFEROSEPTAL SEGMENTCARDIAC MAGNETIC RESONANCE IMAGINGFULL-WIDTH HALF MAXIMUM1SCREENING2023-07-01
24DMD-LGECV202104LGELATE GADOLINIUM ENHANCEMENT

NEGATIVE


NEGATIVE



LEFT VENTRICLECARDIAC MAGNETIC RESONANCE IMAGINGVISUAL1SCREENING2023-07-05
$warningHtml

Dataset Wrapper Debug Message

Please add a row column to your dataset.

The Procedure Agent (AG) dataset is an interventions domain that contains the agents administered to the participant as part of a procedure or assessment. The AG dataset shows the timing of the Gadolinium based contrast, GD-DOTA.  Participant 202 did not have the time the contrast was given available so only the date is represented in AGSTDTC variable.

ag.xpt

ag.xpt

Row

STUDYID

DOMAIN

USUBJID

AGSEQ

AGLNKID

AGTRT

AGCAT

AGDOSE

AGDOSU

AGDOSFRM

AGROUTE

AGSTDTC

1

DMD-LGE

AG

201

1

04

Gd-DOTA

CONTRAST AGENT

8

mL

SOLUTION

INTRAVENOUS

2023-07-01T09:25:00

2

DMD-LGE

AG

202

2

04

Gd-DOTA

CONTRAST AGENT

10

mL

SOLUTION

INTRAVENOUS

2023-07-05

$warningHtml

  • No labels